Current funding for a standard course of 3DCRT for prostate cancer The course of treatment cost using 3DCRT was calculated using current MBS item numbers and the Radiation Oncology Health Program Grant (ROHPG) payments. Table C3a: Cost of current Course of Treatment using Dual Photon 3D-CRT ROHPG MBS Item MBS fee Number of payment per Total number attendance* attendances Description attendance 15550 Simulation $646.30 $101.94 1 $748.24 15562 Dosimetry $1,099.85 $107.44 1 $1,207.29 Treatment $58.55 $55.97 35 $4,008.20 Treatment $170.30 35 $5,960.50 15705 Verification $76.60 11 $842.60 Total $12,767 * As at May 2012 Proposed funding of a course of CyberKnife The costs are based on running a CyberKnife facility that has the capacity to build up to a throughput of 250 patients per year. Two different throughput scenarios were then modelled assuming a ten year life for the capital equipment (CyberKnife). It is important to note that it has been assumed that the predominant cancer treated with CyberKnife (assuming funding) will be prostate cancer. The following economic model determines the cost per fraction using CyberKnife based on this assumption. Table C6: Proposed fees for a standard course of treatment for prostate cancer with CyberKnife MBS Item Claims per MBS fee ROHPG per Description Total cost per patient number patient attendance attendance 15550 Simulation 1 $646.30 $101.94 $748.24 15562 Dosimetry 1 $1,099.85 $107.44 $1,207.29 15xxx Treatment 5 $472.05 $407.82 $4,399.34 15xxx Treatment 5 $1,200.68 n/a $6,003.41 15705 Verification 5 $76.60 n/a $383.00 Total $12,741 The cost per fraction in a course of therapy using CyberKnife for patients with early stage NSCLC unsuited for surgery appears to have been modelled as has been set out in the concurrent submission for prostate cancer.
Current funding for a standard course of 3DCRT for prostate cancer The course of treatment cost using 3DCRT was calculated using current MBS item numbers and the Radiation Oncology Health Program Grant (ROHPG) payments. Table C3a: Cost of current Course of Treatment using Dual Photon 3D-CRT MBS Item number Description MBS fee attendance* ROHPG payment per attendance Number of attendances Total 15550 15562 15705 Simulation Dosimetry Treatment Treatment Verification $646.30 $1,099.85 $58.55 $170.30 $76.60 $101.94 $107.44 $55.97 1 1 35 35 11 $748.24 $1,207.29 $4,008.20 $5,960.50 $842.60 Total $12,767 * As at May 2012 Proposed funding of a course of CyberKnife The costs are based on running a CyberKnife facility that has the capacity to build up to a throughput of 250 patients per year. Two different throughput scenarios were then modelled assuming a ten year life for the capital equipment (CyberKnife). It is important to note that it has been assumed that the predominant cancer treated with CyberKnife (assuming funding) will be prostate cancer. The following economic model determines the cost per fraction using CyberKnife based on this assumption. Table C6: Proposed fees for a standard course of treatment for prostate cancer with CyberKnife MBS Item number Description Claims per patient MBS fee attendance ROHPG per attendance Total cost per patient 15550 Simulation 1 $646.30 $101.94 $748.24 15562 Dosimetry 1 $1,099.85 $107.44 $1,207.29 15xxx Treatment 5 $472.05 $407.82 $4,399.34 15xxx Treatment 5 $1,200.68 n/a $6,003.41 15705 Verification 5 $76.60 n/a $383.00 Total $12,741 The cost per fraction in a course of therapy using CyberKnife for patients with early stage NSCLC unsuited for surgery appears to have been modelled as has been set out in the concurrent submission for prostate cancer.
1158-PSD-Roboticimage-guidedsterotacticprecisebeamradiosurgeryandradiotherapy-Accessible%20(D13-1620678)%20(D13-1647459).docx